566.7000 -15.80 (-2.71%)
NSE Aug 20, 2026 15:31 PM
Volume: 682.1K
 

566.70
-2.71%
ICICI Securities Limited
Thyrocare’s Q2FY24 performance was in line with our expectations. Its revenue grew 9.7% YoY while the franchisee business grew faster at 20%. It reported an improvement in gross margins (+100bps YoY) due to a decline in the lowmargin Partnership business.
Thyrocare Tech has lost -11.86% in the last 1 Week
More from Thyrocare Technologies Ltd.
Recommended